Fundraising Fox

Harbinger Health

1 known investors

harbinger-health.com ↗

Harbinger Health develops RESOLVE, a set of blood-based cancer detection solutions built on its Harbinger HX platform, which uses a developmental biology and cfDNA methylation approach to identify the earliest biological signals of cancer. The tests are aimed at clinicians and patients to resolve uncertainty between suspicion of cancer and diagnosis.

BiotechDigital HealthHealthtech

Investors · 1

Flagship PioneeringCambridge · $500K – $10M

Funding

SEC filings, press & company announcements

$100M disclosed across 1 round · 2026

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Cambridge Biotech Harbinger Health Raises $100M to Launch 12-Cancer Blood Tests - Cambridge Todaynationaltoday.com · Apr 2026Harbinger Health raises $100M for new suite of blood-based cancer detection tests | Fierce Biotechfiercebiotech.com · Apr 2026About - Harbinger Healthharbinger-health.com · Feb 2026Harbinger Health Raises $140M in Series B | citybizcitybiz.co · Sep 2023Harbinger Health raises $140M to study blood-based cancer screening test | MedTech Divemedtechdive.com · Sep 2023Harbinger Health Raises $140 Million in Series B Funding to Accelerate Advancement of its Screening Platform for Early-Stage Cancers - Harbinger Healthharbinger-health.com · Sep 2023

Frequently asked questions

What does Harbinger Health do?
Harbinger Health develops RESOLVE, a set of blood-based cancer detection solutions built on its Harbinger HX platform, which uses a developmental biology and cfDNA methylation approach to identify the earliest biological signals of cancer. The tests are aimed at clinicians and patients to resolve uncertainty between suspicion of cancer and diagnosis.
Who are Harbinger Health's investors?
Harbinger Health's investors include Flagship Pioneering.
How much funding has Harbinger Health raised?
Harbinger Health has disclosed $100M raised across 1 round.